SIM
MDT icon

Studio Investment Management’s Medtronic MDT Stock Holding History

Studio Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
16,289
+1,673
+11% +$135K 0.22% 71
2026
Q1 		$1.28M Buy
14,616
+548
+4% +$52.5K 0.23% 66
2025
Q4 		$1.36M Buy
14,068
+95
+0.7% +$9.23K 0.25% 62
2025
Q3 		$1.34M Buy
13,973
+1,363
+11% +$125K 0.25% 62
2025
Q2 		$1.11M Buy
12,610
+1,263
+11% +$107K 0.22% 72
2025
Q1 		$1.03M Buy
11,347
+2,432
+27% +$218K 0.21% 73
2024
Q4 		$718K Sell
8,915
-1,435
-14% -$124K 0.15% 89
2024
Q3 		$939K Buy
10,350
+1,085
+12% +$91.3K 0.2% 83
2024
Q2 		$742K Buy
9,265
+1,534
+20% +$126K 0.17% 85
2024
Q1 		$679K Buy
7,731
+2,171
+39% +$185K 0.16% 86
2023
Q4 		$458K Buy
5,560
+1,833
+49% +$140K 0.12% 99
2023
Q3 		$295K Buy
3,727
+2,355
+172% +$197K 0.08% 128
2023
Q2 		$122K Buy
1,372
+668
+95% +$57.5K 0.03% 146
2023
Q1 		$57.1K Buy
704
+589
+512% +$48K 0.02% 148
2022
Q4 		$8.94K Buy
+115
New +$9.32K ﹤0.01% 171

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Studio Investment Management's MDT Position: Q2 2026 in Review

Studio Investment Management increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $135K and bringing the position to 16,289 shares worth $1.29M. The position accounts for 0.22% of the portfolio, ranked #71.

Studio Investment Management first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Studio Investment Management held 16,289 shares of Medtronic worth $1.29M as of Q2 2026.
  • Studio Investment Management bought 1,673 Medtronic shares in Q2 2026, an estimated $135K.
  • Medtronic made up 0.22% of Studio Investment Management's portfolio in Q2 2026, its #71 holding.
  • Studio Investment Management first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Studio Investment Management's Medtronic position peaked at $1.36M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.